Literature DB >> 26235959

Association of age and BMI with kidney function and mortality: a cohort study.

Jun Ling Lu1, Miklos Z Molnar1, Adnan Naseer2, Margit K Mikkelsen1, Kamyar Kalantar-Zadeh3, Csaba P Kovesdy4.   

Abstract

BACKGROUND: Compared with normal weight, obesity might be associated with worse clinical outcomes, including chronic kidney disease. Whether this association is modified by age is not known. We investigated the association of BMI with progressive loss of kidney function and all-cause mortality in US veterans.
METHODS: In a national cohort of 3,376,187 US veterans with an estimated glomerular filtration rate (eGFR) of more than 60 mL/min per 1·73 m(2), we assessed the association of BMI in patients of different ages (<40 years, 40 years to <50 years, 50 years to <60 years, 60 years to <70 years, 70 years to <80 years, and ≥80 years) with loss of kidney function and with all-cause mortality in logistic regression models and Cox proportional hazards models adjusted for ethnic origin, sex, comorbidities, medications, and baseline eGFR.
FINDINGS: 274,764 (8·1%) of 3,376,187 veterans had a rapid decline in kidney function (decrease in slope of >5 mL/min per 1·73 m(2)). The lowest risk for loss of kidney function was noted in patients with BMI of at least 25 kg/m(2) but less than 30 kg/m(2). A generally consistent U-shaped association was noted between BMI and rapid loss of kidney function that was more prominent with increasing age, except in the patients younger than 40 years, in whom BMI did not seem to be predictive of renal function impairment. 672,341 veterans died (28·7 per 1000 patient-years, 95% CI 28·6-28·7) over a median follow-up of 6·8 years (IQR 6·5-7·7). BMI also showed a U-shaped association with mortality, which was similar in all age groups.
INTERPRETATION: A BMI of 30 kg/m(2) or more is associated with rapid loss of kidney function in patients with eGFR of at least 60 mL/min per 1·73 m(2), and this association is accentuated in older patients. A BMI of 35 kg/m(2) or more is also associated with high mortality. A BMI of at least 25 kg/m(2) but less than 30 kg/m(2) is associated with the best clinical outcomes. FUNDING: National Institute of Health, Memphis VA Medical Center, Long Beach VA Healthcare System, Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, and VA Information Resource Center.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26235959      PMCID: PMC4547884          DOI: 10.1016/S2213-8587(15)00128-X

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  55 in total

1.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

Review 2.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

3.  Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index.

Authors:  Arjan J Kwakernaak; Dorien M Zelle; Stephan J L Bakker; Gerjan Navis
Journal:  J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 10.121

4.  Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.

Authors:  Agustín Escalante; Roy W Haas; Inmaculada del Rincón
Journal:  Arch Intern Med       Date:  2005-07-25

5.  Experimental focal segmental glomerulosclerosis in mice.

Authors:  A Chen; L F Sheu; Y S Ho; Y F Lin; W Y Chou; T C Chou; W H Lee
Journal:  Nephron       Date:  1998       Impact factor: 2.847

6.  Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.

Authors:  Miklos Z Molnar; Hazem M Alhourani; Barry M Wall; Jun L Lu; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

7.  The effect of age on the association between body-mass index and mortality.

Authors:  J Stevens; J Cai; E R Pamuk; D F Williamson; M J Thun; J L Wood
Journal:  N Engl J Med       Date:  1998-01-01       Impact factor: 91.245

8.  Body-mass index and mortality in a prospective cohort of U.S. adults.

Authors:  E E Calle; M J Thun; J M Petrelli; C Rodriguez; C W Heath
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

9.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Authors:  Asaf Vivante; Eliezer Golan; Dorit Tzur; Adi Leiba; Amir Tirosh; Karl Skorecki; Ronit Calderon-Margalit
Journal:  Arch Intern Med       Date:  2012-11-26

10.  Glomerular hyperfiltration and renal disease progression in type 2 diabetes.

Authors:  Piero Ruggenenti; Esteban L Porrini; Flavio Gaspari; Nicola Motterlini; Antonio Cannata; Fabiola Carrara; Claudia Cella; Silvia Ferrari; Nadia Stucchi; Aneliya Parvanova; Ilian Iliev; Alessandro Roberto Dodesini; Roberto Trevisan; Antonio Bossi; Jelka Zaletel; Giuseppe Remuzzi
Journal:  Diabetes Care       Date:  2012-07-06       Impact factor: 19.112

View more
  63 in total

1.  Obesity: Older age and high BMI are associated with increased risk of loss of kidney function.

Authors:  Jessica K Edwards
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

2.  Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events.

Authors:  Jun Ling Lu; Miklos Z Molnar; Jennie Z Ma; Lekha K George; Keiichi Sumida; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Clin Endocrinol Metab       Date:  2016-09-15       Impact factor: 5.958

Review 3.  Podocytes: the Weakest Link in Diabetic Kidney Disease?

Authors:  Jamie S Lin; Katalin Susztak
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

4.  Age and Outcomes Associated with BP in Patients with Incident CKD.

Authors:  Csaba P Kovesdy; Ahmed Alrifai; Elvira O Gosmanova; Jun Ling Lu; Robert B Canada; Barry M Wall; Adriana M Hung; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-21       Impact factor: 8.237

5.  Obesity and kidney disease: hidden consequences of the epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  Pediatr Nephrol       Date:  2017-02-01       Impact factor: 3.714

6.  Robotic Versus Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity: a Systematic Review and Meta-Analysis.

Authors:  Lixia Wang; Liang Yao; Peijing Yan; Dongsheng Xie; Caiwen Han; Rong Liu; Kehu Yang; Tiankang Guo; Limin Tian
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

Review 7.  Muscle wasting in chronic kidney disease.

Authors:  Eduardo A Oliveira; Wai W Cheung; Kalodiah G Toma; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2017-05-15       Impact factor: 3.714

8.  Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes.

Authors:  Aidar R Gosmanov; Jun L Lu; Keiichi Sumida; Praveen K Potukuchi; Connie M Rhee; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy
Journal:  J Hypertens       Date:  2016-05       Impact factor: 4.844

Review 9.  Obesity and kidney disease: hidden consequences of the epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  J Nephrol       Date:  2017-02       Impact factor: 3.902

10.  Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease.

Authors:  Connie M Rhee; Kamyar Kalantar-Zadeh; Vanessa Ravel; Elani Streja; Amy S You; Steven M Brunelli; Danh V Nguyen; Gregory A Brent; Csaba P Kovesdy
Journal:  Mayo Clin Proc       Date:  2018-05       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.